default author photo

Christian Erikstrup

Aarhus University - Department of Clinical Immunology

Aarhus

Denmark

SCHOLARLY PAPERS

6

DOWNLOADS

896

TOTAL CITATIONS

1

Scholarly Papers (6)

1.

Levels of SARS-CoV-2 Antibodies Among Fully-Vaccinated Individuals With Delta or Omicron Variant Breakthrough Infections: A Prospective Cohort Study

Number of pages: 18 Posted: 25 Mar 2022
Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aalborg University - Department of Infectious Diseases, University of Copenhagen - Department of Infectious Diseases, Zealand University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Medicine, Zealand University Hospital - Department of Medicine, University of Copenhagen - Department of Cardiology, University of Copenhagen - Department of Cardiology, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Department of Clinical Medicine, Aarhus University - Department of Clinical Immunology, University of Copenhagen - Department of Public Health, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP and Aarhus University - Department of Infectious Diseases
Downloads 400 (183,570)
Citation 1

Abstract:

Loading...

SARS-CoV-2, COVID-19, vaccination, antibody, serology, breakthrough infection, Omicron, Delta

2.

SARS-CoV-2 Vaccine-Induced Antibodies Protect Against Omicron Breakthrough Infection

Number of pages: 20 Posted: 24 Feb 2023
Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Medicine, Zealand University Hospital - Department of Medicine, University of Copenhagen - Department of Infectious Diseases, University of Copenhagen - Department of Cardiology, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Department of Public Health, Aarhus University - Department of Clinical Immunology, Statens Serums Institut - Infectious Disease Epidemiology & Prevention, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aarhus University - Department of Infectious Diseases and Aarhus University - Department of Infectious Diseases
Downloads 131 (558,171)

Abstract:

Loading...

SARS-CoV-2, Omicron, COVID-19, Breakthrough Infection, Antibodies, Vaccination, Seroconversion, Case-Control

3.

Persistent Symptoms and Sequelae after SARS-CoV-2 Infection Not Requiring Hospitalization: Results from Testing Denmark, a Danish Cross-Sectional Survey

Number of pages: 18 Posted: 17 Mar 2022
Roskilde University - Department of Science and Environment, University of Copenhagen - Department of Cardiology, Statens Serums Institut - Infectious Disease Epidemiology & Prevention, University of Copenhagen - Department of Cardiology, Aalborg University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Statens Serums Institut, University of Copenhagen - Department of Clinical Medicine, Statens Serums Institut, University of Copenhagen - Department of Clinical Immunology, Statens Serums Institut, Odense University Hospital - Department of Infectious Diseases, Statens Serums Institut - Department of Virus and Microbiological Special Diagnostics, Statens Serums Institut, Zealand University Hospital - Department of Infectious Diseases, University of Copenhagen - Department of Public Health, Statens Serums Institut - Department of Infectious Disease Epidemiology, University of Copenhagen - Department of Infectious Diseases, University of Copenhagen - Department of Cardiology, University of Copenhagen - Department of Clinical Medicine, University of Copenhagen - Department of Clinical Medicine, Statens Serums Institut - Infectious Disease Epidemiology & Prevention, Aarhus University - Department of Clinical Immunology, Statens Serums Institut, Statens Serums Institut - Infectious Disease Epidemiology & Prevention, Statens Serums Institut, Statens Serums Institut, Roskilde University - Department of Science and Environment and University of Copenhagen - Department of Clinical Medicine
Downloads 119 (608,822)

Abstract:

Loading...

COVID-19, SARS-CoV-2, long-COVID, post-COVID syndrome, Post-Acute Sequelae of SARS-CoV-2 infection, PASC, point-of-care-test, POCT, cross-sectional survey, quality of life, Health-related quality of life, SF-12, short-form-12, Testing Denmark, Denmark, propensity scores, Odds ratio, matching, risk factors

4.

Reappraisal of Sex Differences in Migraine

Number of pages: 26 Posted: 10 Feb 2022
University of Copenhagen - Department of Neurology, University of Copenhagen - Department of Neurology, University of Copenhagen - Department of Neurology, University of Copenhagen - Department of Neurology, University of Copenhagen - Department of Neurology, Aarhus University - Department of Biomedicine, University of Copenhagen - Department of Neurology, University of Copenhagen - Department of Neurology, University of Copenhagen - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, Aalborg University Hospital - Department of Clinical Immunology, Odense University Hospital - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, University of Copenhagen - Department of Clinical Medicine, Zealand University Hospital - Department of Clinical Immunology, Statens Serums Institut - Department of Epidemiology Research, Copenhagen University - Novo Nordic Foundation Center for Protein Research, Copenhagen University - Novo Nordic Foundation Center for Protein Research, Aalborg University Hospital - Department of Clinical Immunology, University of Copenhagen - Department of Neurology and University of Copenhagen - Department of Neurology
Downloads 104 (669,616)

Abstract:

Loading...

Migraine, Genetics, sex differences, sex-stratification

5.

Estimation of the Seroprevalence and Infection Fatality Rate of the SARS-CoV-2 Omicron Variant Using Antibody Screening of Danish Blood Donors

Number of pages: 24 Posted: 16 May 2022
Aarhus University - Department of Clinical Immunology, Statens Serums Institut, Aarhus University - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, Statens Serums Institut - Infectious Disease Epidemiology & Prevention, Odense University Hospital - Department of Clinical Immunology, Odense University Hospital - Department of Clinical Immunology, University of Copenhagen - Department of Clinical Immunology, University of Copenhagen - Department of Clinical Immunology, Zealand University Hospital - Department of Clinical Immunology, University of Copenhagen - Department of Clinical Immunology, Zealand University Hospital - Department of Clinical Immunology, University of Copenhagen - Department of Clinical Immunology, University of Copenhagen - Department of Clinical Immunology, Aalborg University Hospital - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, Vitalant Research Institute, Statens Serums Institut, Statens Serums Institut, Statens Serums Institut, University of Copenhagen - Department of Clinical Medicine, Statens Serums Institut - Infectious Disease Epidemiology & Prevention and Zealand University Hospital - Department of Clinical Immunology
Downloads 78 (830,555)

Abstract:

Loading...

6.

Real-World Effectiveness of Faecal Microbiota Transplantation (FMT) for First or Second Clostridioides Difficile Infection (CDI): A Cohort Study

Number of pages: 148 Posted: 19 Dec 2023
Aarhus University, Aarhus University, Aarhus University, Aarhus University, Aarhus University, Aarhus University, Aarhus University, Horsens Regional Hospital, Aalborg University, North Denmark Regional Hospital, Viborg Regional Hospital, Gødstrup Hospital, Silkeborg Regional Hospital, Aalborg University, affiliation not provided to SSRN, Aarhus University, Aarhus University, Aarhus University - Department of Clinical Immunology, Aarhus University - Department of Clinical Immunology, Aarhus University and Aarhus University
Downloads 64 (933,592)

Abstract:

Loading...

Clostridioides difficile, diarrhea, faecal microbiota transplantation, FMT